BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 31713264)

  • 21. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
    Laba P; Wang J; Zhang J
    BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent CD44s and STAT3 expression in human clear cell renal cellular carcinoma and its impact on survival.
    Qin J; Yang B; Xu BQ; Smithc A; Xu L; Yuan JL; Li L
    Int J Clin Exp Pathol; 2014; 7(6):3235-44. PubMed ID: 25031744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miRNAs in Prediction of Prognosis in Clear Cell Renal Cell Carcinoma.
    Ran L; Liang J; Deng X; Wu J
    Biomed Res Int; 2017; 2017():4832931. PubMed ID: 29392135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrin α7: a major driver and therapeutic target for glioblastoma malignancy.
    Nunes AM; Barraza-Flores P; Smith CR; Burkin DJ
    Stem Cell Investig; 2017; 4():97. PubMed ID: 29359136
    [No Abstract]   [Full Text] [Related]  

  • 25. Updated European Association of Urology Guidelines: Recommendations for the Treatment of First-line Metastatic Clear Cell Renal Cancer.
    Powles T; Albiges L; Staehler M; Bensalah K; Dabestani S; Giles RH; Hofmann F; Hora M; Kuczyk MA; Lam TB; Marconi L; Merseburger AS; Fernández-Pello S; Tahbaz R; Volpe A; Ljungberg B; Bex A
    Eur Urol; 2018 Mar; 73(3):311-315. PubMed ID: 29223605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrin α7 Is a Functional Marker and Potential Therapeutic Target in Glioblastoma.
    Haas TL; Sciuto MR; Brunetto L; Valvo C; Signore M; Fiori ME; di Martino S; Giannetti S; Morgante L; Boe A; Patrizii M; Warnken U; Schnölzer M; Ciolfi A; Di Stefano C; Biffoni M; Ricci-Vitiani L; Pallini R; De Maria R
    Cell Stem Cell; 2017 Jul; 21(1):35-50.e9. PubMed ID: 28602620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrin α7 is a functional cancer stem cell surface marker in oesophageal squamous cell carcinoma.
    Ming XY; Fu L; Zhang LY; Qin YR; Cao TT; Chan KW; Ma S; Xie D; Guan XY
    Nat Commun; 2016 Dec; 7():13568. PubMed ID: 27924820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. S100P interacts with integrin α7 and increases cancer cell migration and invasion in lung cancer.
    Hsu YL; Hung JY; Liang YY; Lin YS; Tsai MJ; Chou SH; Lu CY; Kuo PL
    Oncotarget; 2015 Oct; 6(30):29585-98. PubMed ID: 26320193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between urinary sodium excretion and pioglitazone-induced edema.
    Nakamura A; Osonoi T; Terauchi Y
    J Diabetes Investig; 2010 Oct; 1(5):208-11. PubMed ID: 24843434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical management of renal cell carcinoma.
    Krabbe LM; Bagrodia A; Margulis V; Wood CG
    Semin Intervent Radiol; 2014 Mar; 31(1):27-32. PubMed ID: 24596437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunohistochemical expression and prognostic relevance of Bmi-1, a stem cell factor, in epithelial ovarian cancer.
    Abd El hafez A; El-Hadaad HA
    Ann Diagn Pathol; 2014 Apr; 18(2):58-62. PubMed ID: 24342665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrin α7 binds tissue inhibitor of metalloproteinase 3 to suppress growth of prostate cancer cells.
    Tan LZ; Song Y; Nelson J; Yu YP; Luo JH
    Am J Pathol; 2013 Sep; 183(3):831-40. PubMed ID: 23830872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of integrin alpha7 mutations in prostate cancer, liver cancer, glioblastoma multiforme, and leiomyosarcoma.
    Ren B; Yu YP; Tseng GC; Wu C; Chen K; Rao UN; Nelson J; Michalopoulos GK; Luo JH
    J Natl Cancer Inst; 2007 Jun; 99(11):868-80. PubMed ID: 17551147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrins: bidirectional, allosteric signaling machines.
    Hynes RO
    Cell; 2002 Sep; 110(6):673-87. PubMed ID: 12297042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrin α7 is overexpressed and correlates with higher pathological grade, increased T stage, advanced TNM stage as well as worse survival in clear cell renal cell carcinoma patients: A retrospective study.
    Chen Y; Wang Y; Cai Z; Fan X; Zhang Y
    J Clin Lab Anal; 2020 Jan; 34(1):e23034. PubMed ID: 31713264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.